EU pays 336 mln euros for doses of AstraZeneca's potential COVID-19 vaccine


BRUSSELS, Aug 27 (Reuters) - The European Commission has paid 336 million euros ($396 million) to secure at least 300 million doses of the potential COVID-1 vaccine being developed by British drug maker AstraZeneca AZN.L, a spokesman said on Thursday.

Brussels signed the deal on behalf of EU states for the supply of at least 300 million doses of its COVID-19 vaccine candidate. It has an option for a further 100 million, the spokesman said.

"We cannot indicate at this stage the specific pricing per dose. However, a significant part of the overall costs are funded by a contribution from the overall ESI funding for vaccines," he said, referring to the bloc's so-called emergency support instrument.

($1 = 0.8479 euros)

(Reporting by Francesco Guaraisco; Writing by Josephine Mason; Editing by Jan Harvey)

((; +44 207 542 7695; Reuters Messaging:

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.